Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

ClinicalTrials.gov ID: NCT01709149

Public ClinicalTrials.gov record NCT01709149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Multi-National, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (BENEFIT-ALS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to evaluate the safety and effectiveness of CK-2017357 when taken with or without riluzole (also called Rilutek®) in patients with Amyotrophic Lateral Sclerosis (ALS).

Study identification

NCT ID
NCT01709149
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cytokinetics
Industry
Enrollment
711 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2012 (Type not available)
Primary completion
Mar 2014 (Actual)
Completion
Mar 2014 (Actual)
Last update posted
Mar 31, 2020

2012 – 2014

United States locations

U.S. sites
44
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Barrow Neurology Phoenix Arizona 85013 —
University of California, San Diego La Jolla California 92093 —
UC Irvine ALS & Neuromuscular Center Orange California 92868 —
Coordinated Clinical Research San Diego California 92103 —
California Pacific Medical Center Forbes Norris MDA/ALS Research Center San Francisco California 94115 —
Hospital for Special Care New Britain Connecticut 06053 —
The George Washington University Washington D.C. District of Columbia 20037 —
Mayo Clinic Florida Department of Neurology Jacksonville Florida 32224 —
Emory University, School of Medicine Atlanta Georgia 30322 —
Georgia Health Sciences University Augusta Georgia 30912 —
Indiana University Department of Neurology Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Kansas Kansas City Kansas 66160 —
Johns Hopkins University Baltimore Maryland 21205 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
University of Michigan Ann Arbor Michigan 48109 —
Henry Ford Hospital Detroit Michigan 48202 —
St Mary's Healthcare Grand Rapids Michigan 49503 —
Hennepin County Medical Center - Berman Center for Research Minneapolis Minnesota 55415 —
Saint Louis University St Louis Missouri 63104 —
Washington University St Louis Missouri 63110 —
Neurology Associates Lincoln Nebraska 68506 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Hospital for Special Surgery New York New York 10021 —
University of Rochester Rochester New York 14642 —
SUNY Upstate Medical University Syracuse New York 13120 —
Carolinas Medical Center Department of Neurology Charlotte North Carolina 27406 —
Duke University Durham North Carolina 27705 —
Wake Forest University, School of Medicine Winston-Salem North Carolina 27157 —
Ohio State University Department of Neurology Columbus Ohio 43221 —
Providence ALS Center Portland Oregon 97213 —
Oregon Health & Science University Portland Oregon 97239 —
Penn State Hershey Neuroscience Clinics Hershey Pennsylvania 17033 —
Drexel Neurology Philadelphia Pennsylvania 19107 —
University of Pennsylvania Philadelphia Pennsylvania 19107 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Texas Neurology Dallas Texas 75214 —
Baylor College of Medicine Houston Texas 77030 —
UTHSCSA Department of Neurology San Antonio Texas 78229 —
University of Virginia Charlottesville Virginia 22908 —
West Virginia University Department of Neurology Morgantown West Virginia 26506 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01709149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2020 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01709149 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →